Ultrasensitive in-vitro Detection Assay for Non-invasive Alzheimer’s Disease Diagnosis

See Lok Ho, Hei-Nga Chan, Hung-Wing LI*, Man-Shing Wong*

*Corresponding author for this work

Research output: Contribution to journalJournal articlepeer-review


Alzheimer’s disease (AD) is the most prevalent cause of dementia. According to the Alzheimer’s Disease Association, there are over 37 million patients currently suffering from AD. To date, there is still no standard method for accurate AD diagnosis. Detection of biomarkers has become a new trend for disease diagnosis as research has shown that alternation of the expression profile of biomarkers occurs over 10 years before the development of any symptoms. Recently, there is a considerable development in the field of ultrasensitive detection assay for AD diagnosis. This perspective gives an updated review of the current state of development on body fluid-based detection assay for non-invasive AD diagnosis.
Original languageEnglish
Article number190035
JournalGeneral Chemistry
Issue numberSpecial Issues: Bioanalysis
Publication statusE-pub ahead of print - Dec 2020

User-Defined Keywords

  • Alzheimer’s disease
  • biomarkers
  • non-invasive
  • diagnosis
  • immunoassay


Dive into the research topics of 'Ultrasensitive in-vitro Detection Assay for Non-invasive Alzheimer’s Disease Diagnosis'. Together they form a unique fingerprint.

Cite this